No CrossRef data available.
Article contents
Selection criteria for the psychopharmacological treatment of psychiatric disorders in children and adolescents
Published online by Cambridge University Press: 18 September 2015
Summary
This review gives information on selection criteria for the psychopharmacological treatment of psychiatric disorders in children and adolescents, and offers practical instructions for the use of these drugs. Unless mentioned otherwise, the data on effectiveness and safety have been based on controlled trials. In addition, advices are given with respect to drugs that have proved to be effective and safe in adult psychiatric patients but have not yet been investigated sufficiently in children and adolescents.
Keywords
- Type
- Research Article
- Information
- Copyright
- Copyright © Scandinavian College of Neuropsychopharmacology 1994
References
Literatuur
1.Rutter, M, Taylor, E, Hersov, L.Child and adolescent Psychiatry: Modern Approaches. 3rd ed. Oxford: Blackwell, 1994.Google Scholar
2.Gualtieri, CT.Neuropsychiatry and behavioral Pharmacology. New York: Springer, 1991.CrossRefGoogle Scholar
3.Gordon, CT, State, RC, Nelson, JE, Hamburger, SD, Rapoport, JL.A double -blind comparison of clomipramine, desipramine, and placebo in the treatment of Autistic Disorder. Arch gen Psychiat 1993;50:41–7.CrossRefGoogle ScholarPubMed
4.Pelham, WE, Hinshaw, SP.Behavioral intervention for attention deficit-hyperactivity disorder. In: Turner, SM, Calhoun, KS, Adams, HE, eds. Handbook of clinical Behavior Therapy. New York: Wiley, 1992:259–83.Google Scholar
5.Gunning, WB.Medicamenteuze behandelingsmogelijkheden. In: Buitelaar, JK, red. Diagnostiek en Behandeling van ADHD. Utrecht: Stichting Onderwijs en Voorlichting, 1993:91–105.Google Scholar
6.Biederman, J, Baldessarini, RJ, Wright, V, Knee, D, Harmatz, JS.A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. J Am Acad Child Adolesc Psychiat 1989;28:777–84.CrossRefGoogle ScholarPubMed
7.Chase, TN, Friedhoff, AJ, Cohen, DJ.Tourette syndrome: genetics, neurobiology, and treatment. Adv Neurol 1992;58.Google Scholar
8.Spencer, T, Biederman, J, Kerman, K, Steingard, R, Wilens, T.Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. J Am Acad Child Adolesc Psychiat 1993;32:354–60.CrossRefGoogle ScholarPubMed
9.Robertson, MM, Eapen, V.Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome. Clin Neuropharmacol 1992;15:408–25.CrossRefGoogle ScholarPubMed
10.Gadow, KD, Nolan, EE, Sverd, J, Sprafkin, J, Paolicelli, L.Methylphenidate in aggressive-hyperactive boys: I. Effects on peer agres-sion in public school settings. J Am Acad Child Adolesc Psychiat 1990;29:710–8.CrossRefGoogle Scholar
11.Stewart, JT, Myers, WC, Burket, RC, Lyles, WB.A review of the pharmacotherapy of aggression in children and adolescents. J Am Acad Child Adolesc Psychiat 1990;29:269–77.CrossRefGoogle ScholarPubMed
12.Alessi, N, Naylor, MW, Ghaziuddin, M, Zubieta, JK.Update on lithium carbonate therapy in children and adolescents. J Am Acad Child Adolesc Psychiat 1994;33:291–304.CrossRefGoogle ScholarPubMed
13.RG van, Putten. Dipiperon, een buitenbeentje onder de neuroleptica. Janssen Nieuws 1990;5:55–60.Google Scholar
14.Ricketts, RW, Goza, AB, Ellis, CR, et al.Clinical effects of buspirone on intractable self-injury in adults with mental retardation. J Am Acad Child Adolesc Psychiat 1994;33:270–6.CrossRefGoogle ScholarPubMed
15.Osman, OT, Loschen, EL.Self-injurious behavior in the developmentally disabled: pharmacologic treatment. Psychopharmacol Bull 1992;28:439–49.Google ScholarPubMed
16.Campbell, M, Anderson, LT, Small, AM, Adams, P, Gonzalez, NM, Ernst, M.Naltrexone in autistic children: behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiat 1993;32:1283–91.CrossRefGoogle ScholarPubMed
17.DeVeaugh-Geiss, J, Moroz, G, Biederman, J, et al.Clomipramine hydrochloride in childhood and adolescent Obsessive-Compulsive Disorder - a multicenter trial. J Am Acad Child Adolesc Psychiat 1992;31:45–9.CrossRefGoogle ScholarPubMed
18.Riddle, MA, Scahill, L, King, RA, et al.Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with Obsessive-Compulsive Disorder. J Am Acad Child Adolesc Psychiat 1992;31:1062–9.CrossRefGoogle ScholarPubMed
19.Apter, A, Ratzoni, G, King, RA, et al.Fluvoxamine open-label treatment of adolescent inpatients with Obsessive-Compulsive Disorder or Depression. J Am Acad Child Adolesc Psychiat 1994;33:342–8.CrossRefGoogle ScholarPubMed
20.Ryan, ND.Pharmacological treatment of major depression. In: Shafii, M, Shafii, SL, eds. Clinical Guide to Depression in Children and Adolescents. Washington DC: Am Psychiat Press 1992:219–32.Google Scholar
21.Ambrosini, PJ, Bianchi, MD, Rabinovich, H, Elia, J.Antidepressant treatments in children and adolescents: I. Affective disorders. J Am Acad Child Adolesc Psychiat 1993;32:1–6.CrossRefGoogle ScholarPubMed
22.Popper, CW.Psychopharmacologic treatment of anxiety disorders in adolescents and children. J clin Psychiat 1993;54(suppl):52–63.Google ScholarPubMed
23.Wilens, TE, Biederman, J, Spencer, T.Clonidine for sleep disturbances associated with Attention-deficit Hyperactivity Disorder. J Am Acad Child Adolesc Psychiat 1994;33: 424–6.CrossRefGoogle ScholarPubMed
24.A van, Londen, WM van, Londen-Barentsen. De wek-training bij de behandeling van enuresis nocturna: het wekapparaat als ‘prompt’ voor gewenst gedrag. Gedragstherapie 1991;24:223–33.Google Scholar
25.Miller, K, Atkin, B, Moody, ML.Drug therapy for nocturnal enuresis: current treatment recommendations. Drugs 1992;44:47–56.CrossRefGoogle ScholarPubMed
26.Wilsher, CR, Bennet, D, Chase, CH, et al.Piracetam and dyslexia: effects on reading tests. J clin Psychopharmacol 1987;7:230–7.CrossRefGoogle ScholarPubMed